A single-center, open-label, adaptive, two-period, single oral dose, phase I study to assess the period effect (and the effect of food) on the pharmacokinetics of RO7268489 in healthy participants
-
Healthy Volunteers
For the latest version of this information please go to www.forpatients.roche.com